REGENXBIO Inc. logo RGNX - REGENXBIO Inc.

NEXT EARNINGS: Mar 12, 2026 (in 30 days)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 13
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $27.29 DETAILS
HIGH: $45.00
LOW: $12.00
MEDIAN: $27.00
CONSENSUS: $27.29
UPSIDE: 208.36%
Market Cap: 448.01M
Volume: 2,484,097
Avg Volume: 814,130
52 Week Range: 5.035-16.19
Sector: Healthcare
Industry: Biotechnology
Beta: 1.05
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 353
IPO Date: 2015-09-17
EPS (TTM): -4.59
P/E Ratio: -1.69
Revenue (TTM): 83.33M
Total Assets: 465.99M
Total Debt: 82.03M
Cash & Equiv: 57.53M
Rev Growth (5Y): 18.8%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -59.1%
Debt/Equity: 0.32

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 83.33M 90.24M 112.72M 470.35M 154.57M 35.23M 218.50M 10.39M 4.59M 7.59M 6.12M 6.09M
Net Income (227.10M) (263.49M) (280.32M) 127.84M (111.25M) (94.73M) 99.94M (73.17M) (62.97M) (22.81M) (4.00M) (5.39M)
EPS -4.59 -6.02 -6.50 3.01 -2.98 -2.58 2.73 -2.45 -2.38 -2.49 -0.30 -2.04
Total Assets 465.99M 573.97M 833.27M 1.11B 708.16M 497.91M 543.81M 198.68M 172.73M 221.38M 3.49M 2.51M
Total Debt 82.03M 89.29M 94.80M 86.68M 72.65M 11.29M 5.85M N/A N/A N/A 2.40M 655,000
Cash & Equivalents 57.53M 34.52M 96.95M 345.21M 338.43M 69.51M 75.56M 46.66M 24.84M 54.12M 1.12M 1.12M
Operating Cash Flow (173.12M) (218.41M) (207.49M) 218.88M (54.06M) (107.70M) 104.65M (57.99M) (48.56M) (22.52M) (2.40M) (3.01M)
Free Cash Flow (175.56M) (228.37M) (238.21M) 134.70M (80.93M) (119.42M) 91.37M (65.15M) (56.71M) (23.04M) (2.40M) (3.01M)
FCF per Share -3.55 -5.22 -5.52 3.17 -2.17 -3.25 2.50 -2.18 -2.15 -2.51 -0.18 -1.14
Book Value 259.65M 311.74M 516.20M 764.30M 377.75M 450.20M 508.85M 183.03M 161.74M 216.81M (5.70M) (2.14M)
Cash & ST Investments 234.69M 275.26M 364.64M 457.44M 475.74M 296.21M 319.76M 160.78M 89.55M 114.14M 1.12M 1.12M
ROC Equity -0.87 -0.85 -0.54 0.17 -0.29 -0.21 0.20 -0.40 -0.39 -0.11 N/A N/A